Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: Proposal for an easy strategy

Medical and Pediatric Oncology

Volumn 36, Issue 3, 2001, Pages 352-358

  Szczepański, Tomasz ^a   Willemse, Marja J ^b   Kamps, Willem A ^c   Van Wering, Elisabeth R ^d   Langerak, Anton W ^a   Van Dongen, Jacques J M ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Dutch Childhood Leukemia Study Group   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Acute lymphoblastic leukemia (ALL); Ig and TCR gene rearrangements; Minimal residual disease (MRD); Relapse; Secondary leukemia

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN RECEPTOR; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHILD; CLONE; CONTROLLED STUDY; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; METASTASIS; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

BLOTTING, SOUTHERN; BONE MARROW CELLS; CHILD; DIAGNOSIS, DIFFERENTIAL; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; GENES, T-CELL RECEPTOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; NEOPLASMS, SECOND PRIMARY; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENCE;

EID: 0035095140     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1085     Document Type: Article

References (40)

1. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group
2. Drug therapy: Acute lymphoblastic leukemia
3. Lineage switch in acute leukemia
4. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia
5. Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia
6. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: Implications for the detection of minimal residual disease by polymerase chain reaction analysis
7. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia
8. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia
9. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: Implication for a general strategy of minimal residual disease detection
10. Characterization of clonal immunoglobulin heavy chain and T cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia
11. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia
12. Leukemia after therapy with alkylating agents for childhood cancer
13. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: Report of three cases and review of the literature
14. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
15. Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques
16. Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects
17. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: Recommendations for optimal results
18. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis
19. Southern blot detection of immunoglobulin lambda light chain gene rearrangements for clonality studies
20. Southern blot patterns, frequencies and junctional diversity of T-cell receptor δ gene rearrangements in acute lymphoblastic leukemia
21. Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis
22. Human T cell gamma chain joining regions and T cell development
23. Easy detection of all T cell receptor gamma (TCRG) gene rearrangements by Southern blot analysis: Recommendations for optimal results
24. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implications for selection of PCR targets for detection of minimal residual disease
25. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TALI deletions as PCR targets. Report of The BIOMED-I Concerted Action: Investigation of minimal residual disease in acute leukemia
26. Description of a novel FRI IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies
27. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor αβ lineage
28. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations
29. The human immunoglobulin VH repertoire
30. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus
31. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin
32. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis
33. Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia
34. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
35. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
36. Cross-lineage T-cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: Alternative PCR targets for detection of minimal residual disease
37. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: A new molecular target for detection of minimal residual disease
38. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional regions specific TaqMan probes
39. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR
40. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia